Cocaine self-administration is not dependent upon mesocortical α1 noradrenergic signaling.

Neuroreport 20120328

Structural characteristics of renal glomerular system in ISIAH rats under conditions of chronic stress and preventive hypotensive drug therapy.

Bulletin of experimental biology and medicine 20111201

Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome.

Journal of cataract and refractive surgery 20110801

Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions.

Analytical and bioanalytical chemistry 20110701

Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia.

Urology 20110601

A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.

Drug development and industrial pharmacy 20110601

Time-oriented experimental design method to optimize hydrophilic matrix formulations with gelation kinetics and drug release profiles.

International journal of pharmaceutics 20110404

Risk factors for intraoperative floppy iris syndrome: a meta-analysis.

Ophthalmology 20110401

Norepinephrine antagonists and cancer risk.

International journal of cancer 20110201

[How effective is finasteride?].

Deutsche medizinische Wochenschrift (1946) 20110201

Arylpiperazines for management of benign prostatic hyperplasia: design, synthesis, quantitative structure-activity relationships, and pharmacokinetic studies.

Journal of medicinal chemistry 20110113

Efficacy of three different alpha 1-adrenergic blockers and hyoscine N-butylbromide for distal ureteral stones.

International braz j urol : official journal of the Brazilian Society of Urology 20110101

Effect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebo-controlled randomized clinical trial.

Urologia internationalis 20110101

Identification of a novel form of noradrenergic-dependent respiratory motor plasticity triggered by vagal feedback.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20101215

Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20101101

Antagonism of lateral amygdala alpha1-adrenergic receptors facilitates fear conditioning and long-term potentiation.

Learning & memory (Cold Spring Harbor, N.Y.) 20101001

A pharma-robust design method to investigate the effect of PEG and PEO on matrix tablets.

International journal of pharmaceutics 20100630

Development and validation of an Arabic version of the International Prostate Symptom Score.

BJU international 20100501

Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.

The Journal of urology 20100501

Primary bladder neck dysfunction in children and adolescents III: results of long-term alpha-blocker therapy.

The Journal of urology 20100201

Symptomatic comparison in efficacy on patients with benign prostatic hyperplasia treated with two therapeutic approaches.

Complementary therapies in medicine 20100201

Alpha-1 adrenoceptor stimulation triggers axon-reflex vasodilatation in human skin.

Autonomic neuroscience : basic & clinical 20091203

Amlodipine alone or combined with terazosin improves lower urinary tract disorder in rat models of benign prostatic hyperplasia or detrusor instability: focus on detrusor overactivity.

BJU international 20091201

Role of alpha adrenergic blocker in the management of posterior urethral valves.

Pediatric surgery international 20091201

A round table discussion: case studies of patients with lower urinary tract symptoms.

The Urologic clinics of North America 20091101

Buthus tamulus venom-induced vasosensory reflexes are mediated through efferent pathways in sympathetic and vagal parasympathetics.

Neuroscience letters 20091030

Fluorescent quantification of terazosin hydrochloride content in human plasma and tablets using second-order calibration based on both parallel factor analysis and alternating penalty trilinear decomposition.

Analytica chimica acta 20090914

[Dexketoprofen trometamol in the treatment of chronic prostatitis/chronic pelvic pain syndrome].

Zhonghua nan ke xue = National journal of andrology 20090901

Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.

Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20090801

[Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome].

Zhonghua nan ke xue = National journal of andrology 20090801

Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review.

Systems biology in reproductive medicine 20090801

Direct high-performance liquid chromatography enantioseparation of terazosin on an immobilised polysaccharide-based chiral stationary phase under polar organic and reversed-phase conditions.

Journal of chromatography. A 20090710

A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results.

BJU international 20090701

Efficacy of combined amlodipine/terazosin therapy in male hypertensive patients with lower urinary tract symptoms: a randomized, double-blind clinical trial.

Urology 20090701

Iris morphologic changes related to alpha(1)-adrenergic receptor antagonists implications for intraoperative floppy iris syndrome.

Ophthalmology 20090501

[Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention].

Zhonghua nan ke xue = National journal of andrology 20090501

Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line.

Cancer letters 20090408

alpha(1)-Adrenoceptors augment thermal hyperalgesia in mildly burnt skin.

European journal of pain (London, England) 20090301

Alpha-blocker plus diuretic combination therapy as second-line treatment for nocturia in men with LUTS: a pilot study.

Urology 20090301

Functional screening of adrenergic receptors by measuring intracellular calcium using the FlexStation scanning fluorimeter.

Biotechnology journal 20090301

Terazosin treatment suppresses basic fibroblast growth factor expression in the rat ventral prostate.

Clinical and investigative medicine. Medecine clinique et experimentale 20090201

Adjunctive medical therapy with an alpha-1A-specific blocker after shock wave lithotripsy of lower ureteral stones.

Urologia internationalis 20090101

[Using setegis (terasosine) in early postoperative period after transurethral prostate resection].

Urologiia (Moscow, Russia : 1999) 20090101

Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport.

Oncology research 20090101

Efficacy of alpha-Adrenergic Receptor Blockers in the Treatment of Male Lower Urinary Tract Symptoms.

Reviews in urology 20090101

Noradrenaline triggers muscle tone by amplifying glutamate-driven excitation of somatic motoneurones in anaesthetized rats.

The Journal of physiology 20081201

[Efficacy of electroacupuncture in treating 93 patients with benign prostatic hyperplasia].

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20081101

Fabrication of terazocin-loaded poly(D,L-lactide) microspheres by an ultrasonic spray drying method and their release behaviors.

Journal of nanoscience and nanotechnology 20081001

Combined use of melatonin and terazosin restores bladder contractility in rabbits with partial outlet obstruction.

Urology 20080801

Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats.

American journal of physiology. Renal physiology 20080701

Intraoperative floppy-iris syndrome associated with systemic alpha blockers.

Journal of cataract and refractive surgery 20080701

Impacts of the quinazoline-based alpha1-antagonist, terazosin, and of the sulfonamide derivative, tamsulosin, on serum prostate-specific antigen and prostate volume.

Journal of Korean medical science 20080601

[Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?].

Harefuah 20080601

Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats.

Hypertension (Dallas, Tex. : 1979) 20080401

Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial.

The Journal of urology 20080401

Acute generalized exanthematous pustulosis caused by terazosin hydrochloride.

Journal of drugs in dermatology : JDD 20080401

Effect of peripheral sympathetic nerve dysfunction on salt sensitivity of arterial pressure.

Clinical and experimental pharmacology & physiology 20080301

FPIN's clinical inquiries. Medical treatment of benign prostatic hyperplasia.

American family physician 20080301

Lichenoid drug eruption to terazosin.

The British journal of dermatology 20080201

alpha(1)-Adrenoceptor antagonists prevent paracetamol-induced hepatotoxicity in mice.

British journal of pharmacology 20080201

Comparison of cystometric methods in female rats.

Neurourology and urodynamics 20080101

Comparing the therapeutic outcome of different alpha-blocker treatments for BPH in the same individuals.

International urology and nephrology 20080101

Acute intoxication with terazosin.

The American journal of emergency medicine 20080101

Pharmacokinetic and pharmacodynamic modelling of arterial haemodynamic effects of terazosin in healthy volunteers.

Clinical drug investigation 20080101

Efficacy of an alpha1 blocker in expulsive therapy of lower ureteral stones.

Journal of endourology 20080101

High-dose terazosin therapy (5mg) in Korean patients with lower urinary tract symptoms with or without concomitant hypertension: a prospective, open-label study.

Yonsei medical journal 20071231

Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay.

European journal of pharmacology 20071222

[Efficacy of monotherapy with 15 antihypertensive agents in treating essential hypertension assessed by 24-hour ambulatory blood pressure monitoring].

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20071201

New-onset priapism associated with ingestion of terazosin in an otherwise healthy man.

The journal of sexual medicine 20071101

Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.

The Journal of urology 20071101

A rapid and simple high-performance liquid chromatography method for the determination of human plasma levofloxacin concentration and its application to bioequivalence studies.

Biomedical chromatography : BMC 20071001

[Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension].

Zhonghua nan ke xue = National journal of andrology 20070901

Determination of adenosine effects and adenosine receptors in murine corpus cavernosum.

The Journal of pharmacology and experimental therapeutics 20070801

[Comparison of different drugs on the treatment of benign prostate hyperplasia].

Zhonghua wai ke za zhi [Chinese journal of surgery] 20070715

Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia.

Biological & pharmaceutical bulletin 20070701

Delayed effects of hypotensive drugs on structural characteristics of the renal glomerular system in hypertensive NISAG rats.

Bulletin of experimental biology and medicine 20070601

Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats.

British journal of pharmacology 20070501

Role of alpha(1)-adrenoceptors of the locus coeruleus in self-stimulation of the medial forebrain bundle.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070401

Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.

Clinical therapeutics 20070401

Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.

Chinese medical journal 20070305

The effects of systemic alpha-1 adrenergic antagonists on pupil diameter in rats.

Current eye research 20070301

Terazosin modifies the content of glycosaminoglycans and the activity of matrix metalloproteinase 2 in the rat ventral prostate.

European urology 20070201

[An open randomized comparative trial of efficacy and safety of selective alpha-adrenoblocker setegis (terazosin) in therapy of patients with chronic bacterial prostatitis].

Urologiia (Moscow, Russia : 1999) 20070101

Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study.

International urology and nephrology 20070101

Intraoperative floppy iris syndrome associated with terazosin.

Indian journal of ophthalmology 20070101

[Efficacy of setegis administration after transvesical adenomectomy].

Urologiia (Moscow, Russia : 1999) 20070101

Cardio-protective role of terazosin is possibly mediated through alteration in thyroid function.

European journal of pharmacology 20061203

Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states.

American journal of respiratory and critical care medicine 20061201

The effect of terazosin on functional bladder outlet obstruction in women: a pilot study.

The Journal of urology 20061001

alpha-blocker treatment of urolithiasis.

European urology 20060801

Efficacy of terazosin as a facilitator agent for expulsion of the lower ureteral stones.

Saudi medical journal 20060601

alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction.

BJU international 20060501

Significance of nocturnal hesitancy in treatment of men with lower urinary tract symptoms.

Urology 20060501

Role of CNS alpha1-adrenoceptor activity in central fos responses to novelty.

Synapse (New York, N.Y.) 20060401

Identification, preparation, and characterization of several polymorphs and solvates of terazosin hydrochloride.

Journal of pharmaceutical sciences 20060401

Treatment and pharmacologic management of BPH in the context of common comorbidities.

The American journal of managed care 20060401

In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits.

Naunyn-Schmiedeberg's archives of pharmacology 20060201

More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study.

Prostate cancer and prostatic diseases 20060101

Pharmacologic expulsive treatment of ureteral calculi.

The Annals of pharmacotherapy 20060101

[Using terasosine (setegis) in the treatment of hyperactive urinary bladder in elderly women].

Urologiia (Moscow, Russia : 1999) 20060101

Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg?

Ophthalmology 20051201

Alpha(1)-adrenergic and alpha(2)-adrenergic balance in the dorsal pons and gross behavioral activity of mice in a novel environment.

Psychopharmacology 20051101

Effects of different alpha-1 adrenoceptor blockers on proximal urethral function using in vivo isovolumetric pressure changes.

Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20051001

Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.

Bangladesh Medical Research Council bulletin 20050801

Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.

Urology 20050701

The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens.

Journal of general internal medicine 20050701

Evidence of roles of central alpha1-adrenoceptors and epinephrine in orexin A-induced hyperactivity in mice.

Neuroscience letters 20050624

The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones.

The Journal of urology 20050601

Effect of terazosin on tissue vascularity and apoptosis in transitional cell carcinoma of bladder.

Urology 20050501

High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans.

Journal of clinical pharmacy and therapeutics 20050401

Comparative evaluation of Prostina and terazosin in the treatment of benign prostatic hyperplasia.

Journal of the Indian Medical Association 20050201

Sympathetic modulation of activity in Adelta- and C-primary nociceptive afferents after intradermal injection of capsaicin in rats.

Journal of neurophysiology 20050101

alpha1-Adrenergic receptor antagonists induce production of IL-18 and expression of ICAM-1 and CD40 in human monocytes.

Journal of immunotherapy (Hagerstown, Md. : 1997) 20050101

[Double-blind placebo-controlled trial of terazosine efficacy in patients with chronic abacterial prostatitis].

Urologiia (Moscow, Russia : 1999) 20050101

[Clinical efficacy and safety of terazosine (setegis) in patients with benign prostatic hyperplasia with concomitant cardiovascular diseases].

Urologiia (Moscow, Russia : 1999) 20050101

[Kornam in the treatment of imperative urine incontinence in females].

Urologiia (Moscow, Russia : 1999) 20050101

Terazosin in the treatment of premature ejaculation: a short-term follow-up.

International urology and nephrology 20050101

Sympathetic and angiotensin-dependent hypertension during cage-switch stress in mice.

American journal of physiology. Regulatory, integrative and comparative physiology 20041201

Role of locus coeruleus alpha1-adrenoceptors in motor activity in rats.

Synapse (New York, N.Y.) 20041201

Visceral afferent bias on cortical processing: role of adrenergic afferents to the basal forebrain cholinergic system.

Behavioral neuroscience 20041201

Effects of alpha-1 adrenergic receptor antagonist, terazosin, on cardiovascular functions in anaesthetised dogs.

Indian journal of experimental biology 20041201

Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.

Urology 20041101

Sympathetic influence on capsaicin-evoked enhancement of dorsal root reflexes in rats.

Journal of neurophysiology 20041001

Baroreceptor mediated blood pressure regulation is not affected during dose dependent inhibition of prostatic contractions by terazosin.

Indian journal of physiology and pharmacology 20041001

Gross mapping of alpha1-adrenoceptors that regulate behavioral activation in the mouse brain.

Behavioural brain research 20040709

Meta-analysis: creating a level playing field for the patient with symptomatic benign prostatic hyperplasia?

BJU international 20040701

The role of alpha-blockers in the management of prostate cancer.

Expert opinion on pharmacotherapy 20040601

[The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line].

Zhonghua wai ke za zhi [Chinese journal of surgery] 20040522

Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin.

Naunyn-Schmiedeberg's archives of pharmacology 20040501

Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia.

Expert opinion on pharmacotherapy 20040501

Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?

The Prostate 20040401

Measurement of low-dose active pharmaceutical ingredient in a pharmaceutical blend using frequency-domain photon migration.

Journal of pharmaceutical sciences 20040301

Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs).

Advanced drug delivery reviews 20040223

[Effect of nitric oxide donor and alpha1-receptor antagonist on proliferation/apoptosis of hyperplastic prostatic stromal cells in vitro].

Zhonghua wai ke za zhi [Chinese journal of surgery] 20040222

Herbal and vitamin supplement use in a prostate cancer screening population.

Urology 20040201

A current review of medical therapy for benign prostatic hyperplasia.

The Journal of the American Osteopathic Association 20040201

Validated specific HPLC methods for determination of prazosin, terazosin and doxazosin in the presence of degradation products formed under ICH-recommended stress conditions.

Journal of pharmaceutical and biomedical analysis 20040127

[Combined treatment of voiding disorders in women with m-cholinolytic and alpha 1-adrenoblocker].

Urologiia (Moscow, Russia : 1999) 20040101

Terazosin and doxazosin in the treatment of BPH: results of a randomized study with crossover in non-responders.

Urologia internationalis 20040101

Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hyperplasia.

Journal of managed care pharmacy : JMCP 20040101

The use and rationale of selective alpha blockade in children with non-neurogenic neurogenic bladder dysfunction.

International braz j urol : official journal of the Brazilian Society of Urology 20040101

A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.

Scandinavian journal of urology and nephrology 20040101

Immobility from administration of the alpha1-adrenergic antagonist, terazosin, in the IVth ventricle in rats.

Neuroscience letters 20031226

Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate.

Urology 20031101

Influence of hypertension on lower urinary tract symptoms in benign prostatic hyperplasia.

International journal of urology : official journal of the Japanese Urological Association 20031101

Growth inhibiting effects of terazosin on androgen-independent prostate cancer cell lines.

Chinese medical journal 20031101

[Pharmacologic treatment of benign prostatic hyperplasia].

Orvosi hetilap 20030914

The role of combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Current urology reports 20030801

[Serum nitric oxide and D-dimer before and after administering antihypertensive drugs in essential hypertension].

Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University 20030801

Role of epinephrine stimulation of CNS alpha1-adrenoceptors in motor activity in mice.

Synapse (New York, N.Y.) 20030701

Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.

The Journal of urology 20030701

Effects of intravenous and infravesical administration of suramin, terazosin and BMY 7378 on bladder instability in conscious rats with bladder outlet obstruction.

BJU international 20030701

Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.

The Journal of urology 20030401

Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.

The Journal of urology 20030301

Effect of terazosin on clinical benign prostatic hyperplasia in older adults.

Journal of the American Geriatrics Society 20030301

Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.

The Journal of urology 20030201

Identification of apoptotic and antiangiogenic activities of terazosin in human prostate cancer and endothelial cells.

The Journal of urology 20030201

Nitric oxide opposes glucose-induced hypertension by suppressing sympathetic activity.

Hypertension (Dallas, Tex. : 1979) 20030201

[Hepatotoxicity induced by terazosin].

Medicina clinica 20030201

Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alpha1-adrenergic blockade.

Circulation 20030107

[Results of treatment of irritative symptoms and urinary retention in patients 1 year after radical retropubic prostatectomy].

Urologiia (Moscow, Russia : 1999) 20030101

Plasma atrial natriuretic peptide in essential hypertension after treatment with terazocin.

European journal of drug metabolism and pharmacokinetics 20030101

The alpha1-adrenoceptor antagonist terazosin induces prostate cancer cell death through a p53 and Rb independent pathway.

Oncology reports 20030101

Comparison of finasteride and alpha-blockers as independent risk factors for erectile dysfunction.

International journal of clinical practice 20030101

Mice expressing the alpha(1B)-adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation.

Journal of neurochemistry 20021101

Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.

Urology 20021001

[Comparison of prazosin, terazosin and tramsulosin: functional and binding studies in isolated prostatic and vascular human tissues].

Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20020901

[Effects of terazosine and atenolol on serum lipids in essential hypertension].

Zeitschrift fur Kardiologie 20020901

Prior iontophoresis of saline enhances vasoconstriction to phenylephrine and clonidine in the skin of the human forearm.

British journal of clinical pharmacology 20020701

Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.

The Journal of urology 20020601

[Chiral separation and preparation of three new antagonists of alpha 1-adrenoceptors by chiral mobile phase HPLC].

Yao xue xue bao = Acta pharmaceutica Sinica 20020601

The efficacy of terazosin for treating benign prostatic hyperplasia: a multicentre clinical trial.

BJU international 20020501

Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system.

American journal of physiology. Regulatory, integrative and comparative physiology 20020401

Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms.

The Journal of urology 20020401

Role of supraspinal alpha1-adrenoceptors for voiding in conscious rats with and without bladder outlet obstruction.

The Journal of urology 20020401

Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs.

The Journal of pharmacology and experimental therapeutics 20020201

Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.

Cancer research 20020115

Impact of alpha1-blockers in men with spinal cord injury and upper tract stasis.

The journal of spinal cord medicine 20020101

Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.

Anticancer research 20020101

Apoptotic and proliferative index after Alpha-1-adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia.

Urologia internationalis 20020101

[Treatment of external RF hyperthermia combining with alpha 1-adrenergic receptor blocker for patients with prostatodynia and chronic non-bacterial prostatitis].

Zhonghua nan ke xue = National journal of andrology 20020101

[Comparative evaluation of the efficacy of using terazosin and tamsulosin in patients with benign prostatic hyperplasia].

Urologiia (Moscow, Russia : 1999) 20020101

[Results of monotherapy with terazosin (kornam) in chronic infectious prostatitis patients].

Urologiia (Moscow, Russia : 1999) 20020101

[Use of alpha1-adrenergic blockaders in voiding disorders in women].

Urologiia (Moscow, Russia : 1999) 20020101

Terazosin for benign prostatic hyperplasia.

The Cochrane database of systematic reviews 20020101

Terazosin, doxazosin, and prazosin: current clinical experience.

Urology 20011201

5alpha-reductase inhibitors: what role should they play?

Urology 20011201

Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia.

Urology 20011101

Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin.

The Prostate 20010701

Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.

Journal of medicinal chemistry 20010607

Comparison of prazosin, terazosin and tamsulosin: functional and binding studies in isolated prostatic and vascular human tissues.

The Prostate 20010601

Pharmacological blockade of brain alpha1-adrenoceptors as measured by ex vivo [3H]prazosin binding is correlated with behavioral immobility.

European journal of pharmacology 20010525

Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations.

Journal of clinical epidemiology 20010501

Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study.

Clinical therapeutics 20010501

The short-term effects of terazosin in Japanese men with benign prostatic hyperplasia.

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20010401

Overstimulation of the alpha1B-adrenergic receptor causes a 'seizure plus' syndrome.

Nature medicine 20010201

Magnetic resonance imaging and morphometric histologic analysis of prostate tissue composition in predicting the clinical outcome of terazosin therapy in benign prostatic hyperplasia.

International journal of urology : official journal of the Japanese Urological Association 20010201

[A randomized comparative study assessing once versus twice a day treatment of benign prostatic hyperplasia with terazosin].

Hinyokika kiyo. Acta urologica Japonica 20010201

alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it.

The Journal of urology 20010101

Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months.

Urology 20010101

Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia.

The Prostate 20010101

A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors.

Naunyn-Schmiedeberg's archives of pharmacology 20010101

[The efficacy and safety of terazosin and tamsulosin in patients with urinary disturbance accompanying prostatic hypertrophy].

Hinyokika kiyo. Acta urologica Japonica 20010101

Effect of terazosin on the lipid profile in patients with symptomatic benign prostatic hyperplasia.

Urologia internationalis 20010101

Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia.

International urology and nephrology 20010101

Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index.

International urology and nephrology 20010101

High-performance liquid chromatographic analysis and pharmacokinetics of terazosin in healthy volunteers.

Research communications in molecular pathology and pharmacology 20010101

Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.

Cancer research 20000815

Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.

The Journal of urology 19990601

A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.

European urology 19990101

Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive men.

British journal of urology 19980901

Effects of oral and intravenous terazosin and head-up tilt on blood pressure responses in patients with hypertension.

Journal of clinical pharmacology 19980601

4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.

Journal of medicinal chemistry 19980409

A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing.

European urology 19980101

Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.

Journal of medicine 19980101

Synthesis and pharmacological characterization of 3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e] isoindol-2-yl)ethyl]pyrido-[3',4':4,5]thieno[3,2-d]pyrimidine-2,4 (1H,3H)-dione (A-131701): a uroselective alpha 1A adrenoceptor antagonist for the symptomatic treatment of benign prostatic hyperplasia.

Journal of medicinal chemistry 19970926

Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes.

The Prostate 19970915

Side effects of terazosin in the treatment of symptomatic benign prostatic hyperplasia.

Southern medical journal 19970501

Prostatic alpha 1-adrenoceptors and uroselectivity.

The Prostate 19970215

Coma from the health food store: interaction between kava and alprazolam.

Annals of internal medicine 19961201

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.

Urology 19960301

Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy.

European journal of pharmacology 19950116

Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.

Urology 19940701

Effects of ANG-converting enzyme and alpha 1-adrenoceptor inhibition on intrarenal hemodynamics in SHR.

The American journal of physiology 19940501

The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.

Molecular pharmacology 19940401

[Use of terazosin and alfuzosin in the treatment of benign prostatic hypertrophy (BPH): our experience].

Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma 19940101

Intraoperative hypotension in a patient treated with terazosin, a new alpha-adrenergic receptor antagonist.

Journal of clinical anesthesia 19940101

[Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 19920301

The efficacy and safety of terazosin for the treatment of symptomatic BPH.

The Prostate 19910101